Netherlands: A European Leader in Healthcare Innovation with over 3100 R and D companies

The Dutch healthcare system emphasizes equality and access, making it a priority sector with a vibrant research and business ecosystem that's conducive to innovation. The Netherlands is recognized as a leading innovator in life sciences and health within the EU, investing over €2 billion annually in R&D. It boasts a robust network of 3,100 R&D companies, 420 biopharmaceutical companies, and a €4.7-billion MedTech market, supported by renowned academic and research institutions. Regional innovation hubs, like Utrecht Science Park and Amsterdam Science Park, alongside key institutions like the European Medicines Agency, fuel the sector's collaborative and interconnected nature. Read more here.